Literature DB >> 16566677

Chinese medicinal herbs for influenza: a systematic review.

Xiaoyan Chen1, Taixiang Wu, Guanjian Liu.   

Abstract

BACKGROUND: Influenza is an acute respiratory communicable disease which can cause high morbidity and mortality in an epidemic. Traditional Chinese medicinal herbs following a particular theory may be a potential medicine of choice.
OBJECTIVES: We aim to assess the therapeutic effect and adverse reaction of traditional Chinese medicinal herbs in the treatment of uncomplicated influenza. SEARCH STRATEGY: We searched the Cochrane Library, MEDLINE, EMBASE, CBM, and handsearched the relevant Chinese journals. SELECTION CRITERIA: Randomised and quasi-randomised trials compared with placebo, or with other chemical drugs normally used in care, or various other Chinese medicinal herbs amd chemical drugs with herbal preparations compared with simple chemical drugs were also included. DATA COLLECTION AND ANALYSIS: At least two reviewers extracted data and assessed trial quality. MAIN
RESULTS: We included 8 relevant studies, most of which were of low quality. Because of the clinical heterogeneity, we did not perform a summary meta-analysis. Some of the studies showed positive results favouring Traditional Chinese medicinal herb treatment compared to antiviral or antipyretic-analgesic drugs or the combination of them. Only three studies mentioned adverse reactions but no detailed data were acquired in the included studies. REVIEWERS'
CONCLUSIONS: The small number of included studies and participants, as well as the low quality of most studies, made the evidence far from conclusive for clinical decision making. More high quality randomised controlled trials (RCTs) with similar interventions are required to strengthen the evidence for the efficacy and safety of certain herbal preparations.

Entities:  

Year:  2006        PMID: 16566677     DOI: 10.1089/acm.2006.12.171

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  8 in total

1.  A traditional Chinese medicine versus Western combination therapy in the treatment of rheumatoid arthritis: two-stage study protocol for a randomized controlled trial.

Authors:  Chi Zhang; Miao Jiang; Aiping Lu
Journal:  Trials       Date:  2011-06-04       Impact factor: 2.279

Review 2.  The cytokine storm of severe influenza and development of immunomodulatory therapy.

Authors:  Qiang Liu; Yuan-hong Zhou; Zhan-qiu Yang
Journal:  Cell Mol Immunol       Date:  2015-07-20       Impact factor: 11.530

3.  Chinese herbs in treatment of influenza: a randomized, double-blind, placebo-controlled trial.

Authors:  Lei Wang; Rui-Ming Zhang; Gui-Ying Liu; Bao-Lin Wei; Yang Wang; Hong-Yan Cai; Feng-Sen Li; Yan-Ling Xu; Si-Ping Zheng; Gang Wang
Journal:  Respir Med       Date:  2010-06-22       Impact factor: 3.415

Review 4.  Reynoutria japonica Houtt for Acute Respiratory Tract Infections in Adults and Children: A Systematic Review.

Authors:  Zhi-Jie Wang; Jeanne Trill; Lin-Lin Tan; Wen-Jing Chang; Yu Zhang; Merlin Willcox; Ru-Yu Xia; Yue Jiang; Michael Moore; Jian-Ping Liu; Xiao-Yang Hu
Journal:  Front Pharmacol       Date:  2022-02-24       Impact factor: 5.810

5.  Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.

Authors:  Lisa M Alleva; Charles Cai; Ian A Clark
Journal:  Evid Based Complement Alternat Med       Date:  2009-09-24       Impact factor: 2.629

Review 6.  Characteristics of human infection with avian influenza viruses and development of new antiviral agents.

Authors:  Qiang Liu; Dong-Ying Liu; Zhan-Qiu Yang
Journal:  Acta Pharmacol Sin       Date:  2013-10       Impact factor: 6.150

7.  Maoto, a Traditional Japanese Herbal Medicine, Inhibits Uncoating of Influenza Virus.

Authors:  Shinta Masui; Shigeki Nabeshima; Kazuhiko Ajisaka; Kei Yamauchi; Ryota Itoh; Kazunari Ishii; Toshinori Soejima; Kenji Hiromatsu
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-22       Impact factor: 2.629

8.  Traditional Chinese medicine treatments for upper respiratory tract infections/common colds in Taiwan.

Authors:  Jung-Sheng Yu; Chung-Han Ho; Yao-Chin Hsu; Jhi-Joung Wang; Ching-Liang Hsieh
Journal:  Eur J Integr Med       Date:  2014-06-12       Impact factor: 1.314

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.